N/A
N=14
Precision Orthodontics: A Comparison of Custom vs Traditional Bracket Treatment Efficiency
Dental Malocclusion
Bottom Line
View on ClinicalTrials.gov: NCT04266769 ↗Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Length of Bonding Appointment — 33 minutes
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- LightForce Orthodontic System (Device)
- Age
- Pediatric, Adult, Older Adult · 10+ yrs
- Sex
- All
- Sponsor
- LightForce Orthodontics
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Length of Bonding Appointment |
33 | — |
| PRIMARY Number of Debonded Brackets |
3 | — |
| PRIMARY Length of Treatment |
27 | — |
| PRIMARY Length of Debond Appointment |
60 | — |
| PRIMARY Length of Time to Achieve Leveling and Aligning |
16 | — |
| PRIMARY Number of Unscheduled Appointments |
3 | — |
| PRIMARY Number of Repositioned Brackets |
1 | — |
Summary
This investigational testing aims to target multiple investigations sites to examine treatment efficiency metrics using a completely digital and patient-specific bracket treatment system for the correction of malocclusions.
Eligibility Criteria
Inclusion Criteria
- All subjects must be healthy and between the ages of 10 and 65.
- Eruption of all permanent teeth excluding second and third molars
- Sufficient labial tooth surface for bonding
- No more than one tooth missing from a single arch quadrant
- No existing molar tubes or bands
Exclusion Criteria
- Presence of systemic diseases, cleft lip and palate, craniofacial anomalies, syndromes affecting bone or teeth, impacted teeth (excluding 3rd molars), and tumors of the parathyroid gland
- Presence of bridges or implants
- Cases requiring orthognathic surgery
- Significant periodontal disease
- Intake of drugs affecting tooth movement or bone formation (chronic use of Non-Steroidal Anti-Inflammatory Drugs, bisphosphonates, levothyroxine, or teriparatide drug class)
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT04266769). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.